MEIRAGTX HOLDINGS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.99 USD | -2.92% |
|
-11.84% | -28.92% |
| May. 15 | Transcript : MeiraGTx Holdings plc Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM | |
| May. 09 | Earnings Flash (MGTX) MEIRAGTX Reports Q1 Revenue $697,000 | MT |
Chart calendar MeiraGTx Holdings plc
5929533bbaa6398ef2791.FMWT5clRp1GEBSBSfyDm8r6LTp6Qfy64-HnepY4Zx3o.epHjjq0O7AbwY0koPXCqg4vcBvTiPXz2mk-ulf9a6hVbrOG98WPTF8dQEA~14342b11efcbe228fff09ef0f7897d8a
Upcoming events on MeiraGTx Holdings plc
Past events on MeiraGTx Holdings plc
| 2024-05-15 01:40 pm | BofA Securities Health Care Conference |
| 2024-05-13 | RBC Capital Markets Global Healthcare Conference |
| 2024-05-09 08:00 am | Q1 2024 Earnings Release |
| 2024-04-29 11:00 am | Chardan Genetic Medicines and Cell Therapy Manufacturing Summit |
| 2024-04-16 04:20 pm | American Academy of Oral Medicine Meeting - Presentation ID #196 |
| 2024-03-14 08:30 am | Q4 2023 Earnings Release |
| 2023-11-30 09:00 am | Piper Sandler Healthcare Conference |
| 2023-11-28 10:25 am | Evercore ISI HealthCONx Conference |
| 2023-11-14 08:00 am | Q3 2023 Earnings Release |
| 2023-10-27 05:00 am | European Society of Gene and Cell Therapy Congress |
| 2023-10-23 | European Society of Gene and Cell Therapy Congress - Poster Number: 464 |
| 2023-10-23 | European Society of Gene and Cell Therapy Congress - Poster Number: 008 |
| 2023-10-23 | European Society of Gene and Cell Therapy Congress - Poster Number: 334 |
| 2023-10-23 | European Society of Gene and Cell Therapy Congress - Poster Number: 431 |
| 2023-10-23 | European Society of Gene and Cell Therapy Congress - Poster Number: 122 |
| 2023-10-23 | European Society of Gene and Cell Therapy Congress - Poster Number: 324 |
| 2023-10-23 | European Society of Gene and Cell Therapy Congress - Poster Number: 167 |
| 2023-10-23 | European Society of Gene and Cell Therapy Congress - Poster Number: 116 |
| 2023-08-10 08:00 am | Q2 2023 Earnings Release |
| 2023-07-31 | American Society of Gene and Cell Therapy Conference - Poster Number: 21 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13,3 6,50 104.49% | 15,6 17,2 -9.28% | 37,7 22,8 65.55% | 15,9 32,7 -51.29% | 14,0 18,6 -24.44% | 49,8 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -58,4 -61,4 4.86% | -65,3 -85,3 23.43% | -108 -76,0 -41.71% | -123 -53,5 -130.47% | -98,6 |
|
EBIT Million USD | Released Forecast Spread | -58,3 -73,0 20.18% | -62,6 -66,3 5.61% | -73,2 -95,6 23.41% | -116 -94,7 -22.88% | -137 -123 -11.8% | -124 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -54,7 -69,5 21.23% | -58,0 -64,6 10.28% | -79,6 -98,7 19.38% | -130 -126 -2.57% | -84,0 -135 37.57% | -108 |
|
Net income Million USD | Released Forecast Spread | -54,7 -69,5 21.23% | -58,0 -63,9 9.3% | -79,6 -97,5 18.36% | -130 -124 -4.67% | -84,0 -135 37.57% | -108 |
|
EPS USD | Released Forecast Spread | -1,65 -2,10 21.43% | -1,54 -1,68 8.33% | -1,80 -2,09 13.71% | -2,87 -2,66 -7.81% | -1,49 -1,88 20.91% | -1,55 |
| Announcement Date | 11/03/20 | 11/03/21 | 10/03/22 | 14/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,63 4,63 21.79% | 10,8 6,99 53.82% | 4,82 10,7 -55.14% | -5,29 8,76 -160.4% | 3,33 4,87 -31.47% | 3,54 4,17 -15.05% | 5,10 3,27 56.06% | 2,04 6,56 -68.91% | 0,70 9,69 -92.81% | 9,69 | 9,69 | 10,6 | 9,95 | 26,7 |
|
EBIT Million USD | Released Forecast Spread | -28,7 -24,6 -16.69% | -23,8 -27,1 12.2% | -22,8 -25,2 9.66% | -41,1 -26,7 -53.67% | -31,8 -33,6 5.57% | -28,8 -33,5 14.16% | -32,8 -33,7 2.87% | -43,8 -29,4 -48.63% | -46,8 -31,4 -49.13% | -26,5 | -28,2 | -28,5 | 12,6 | 16,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -31,0 -23,5 -32.11% | -34,0 -26,4 -28.52% | -37,3 -25,3 -47.39% | -27,3 -31,1 12.27% | -30,4 -34,4 11.82% | -29,6 -34,4 14.04% | -44,3 -35,3 -25.64% | 20,2 -30,5 166.33% | -20,4 -31,9 35.99% | -27,5 | -29,2 | -29,9 | 11,6 | 15,7 |
|
Net income Million USD | Released Forecast Spread | -31,0 -23,5 -32.11% | -34,0 -26,4 -28.52% | -37,3 -25,3 -47.39% | -27,3 -31,1 12.27% | -30,4 -34,4 11.82% | -29,6 -34,4 14.04% | -44,3 -35,3 -25.64% | 20,2 -30,5 166.33% | -20,4 -31,9 35.99% | -27,5 | -29,2 | -29,9 | 11,6 | 15,7 |
|
EPS USD | Released Forecast Spread | -0,70 -0,51 -38.16% | -0,76 -0,62 -22.58% | -0,83 -0,58 -44.35% | -0,58 -0,49 -19.18% | -0,62 -0,66 5.58% | -0,53 -0,57 6.47% | -0,74 -0,55 -35.37% | 0,42 -0,48 187.5% | -0,32 -0,51 36.63% | -0,40 | -0,43 | -0,42 | 0,17 | 0,23 |
| Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 14/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 14/03/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for MeiraGTx Holdings plc
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MGTX Stock
- Calendar MeiraGTx Holdings plc
